• Home
  • GELITA AG
  • Heavy Crosslinking Due to Novel Plant Extracts – Challenge Accepted With Rxl® Ultra
Video
25 Oct 2024

Heavy Crosslinking Due to Novel Plant Extracts – Challenge Accepted With Rxl® Ultra

Existing and upcoming trends for plant-based extracts represent a challenge for softgel manufacturers – as potential extreme crosslinking components.

  • With RXL® Ultra, GELITA re-focusses on an established, but hidden/un-noticed, solution to conquer these crosslinking challenges. As part of the RXL®-product family, the modified gelatin RXL® Ultra is the benchmark in anti-crosslinking performance for gelatin based excipients. While maintaining the known benefits in softgel production for gelatin, it provides ultimate potential to solve even extreme crosslinking and – in the end – deliver reliable products to the consumer.
  • This session will also provide insights on the regulatory background for RXL® Ultra and how to overcome challenges when used as capsule material.

    • Content provided by our supplier

    GELITA AG

    • DE
    • 2023
      On CPHI since
    • 1000 - 4999
      Employees
    Company types
    Manufacturer/Innovator
    Primary activities
    Excipients Manufacturer
    View company profile

    Other Content from GELITA AG ()